The Canadian Government Proposes Amendments to the Regulation of Drug Pricing

Posted on June 1, 2017
North America

By Richard Y. Cheung, Ph.D., Toronto, Fasken Martineau DuMoulin

Due to concerns about the growing percentage of the health care budget allotted to drug spending in Canada and the relative drug prices in Canada compared to other developed countries, the Canadian government is proposing changes to the way in which prices for patented drugs are regulated …

Read or download the full article below.

Tags: Canada, Life Sciences
Latest Updates
The Greater China IP Updates – July 2024
An Essential Guide to Securing a 9(g) Commercial Visa in the Philippines
A Seat at the Table – Why in-House Counsel is Crucial for ESG success
Related Articles
The Greater China IP Updates – July 2024
An Essential Guide to Securing a 9(g) Commercial Visa in the Philippines
A Seat at the Table – Why in-House Counsel is Crucial for ESG success
Related Articles by Jurisdiction
SOUTH KOREA: Amendment of Korean Fair Trade-related Laws
The Moon administration is seeking reforms in a variety of areas of the Korean economy, based on its vision of “an economy pursuing co-prosperity” ...
Canada: Consent is Becoming a Topic of Conversation Again
Overview of The Annual Report of The Office of The Privacy Commissioner of Canada ...
N. America: Northern Gateway Pipeline
Province must consult and decide but may impose conditions
Latest Articles
Simmons Names New Regulatory Head in Hong Kong
Atsumi & Sakai Opens new Office in Ho Chi Minh
Gorriceta Africa Cauton & Saavedra Names Three New Practice Group Heads